Serum provided a commitment of $40M for clinical trials. $ENZC has indicated that they are ready and believe combining the 2 therapies (monoclonal antibody known as "CLONE 3" + pepsin ITV-1) will yield amazing results.
CLONE 3 alone has been validated as 95-98% effective at neutralizing multiple strains of HIV by our top institutions: Harvard, Duke, USF, Cal, UVienna.
They are ready for the next step and its a matter of finalizing the paperwork at this point.
With #OperationWarpSpeed underway, and several high level, well-connected individuals on our Board, they've been working overtime and making incredible progress. Great PRs last week.